Thank you to our Foundational and Sustaining members
Company secured more than $2 million in seed funding to support advancement and commercialization of sample prep technology and novel diagnostic tests CHARLESTON, S.C. & OAKDALE, Minn.–(BUSINESS WIRE)–Veravas, Inc., an emerging diagnostic company, appointed Joshua Soldo as the chief scientific officer and Carmen Wiley, Ph.D., as chief clinical officer. Mr. Soldo and Dr. Wiley have […]
gener8tor, a nationally ranked accelerator program, has partnered with Boston Scientific to launch a healthcare-focused program in Medical Alley with additional support from the University of Minnesota and Mayo Clinic. Their first cohort wrapped up in June and the second cohort was announced in July. Over the next few weeks, we will profile the second […]
Q1 record with 26 Medical Alley companies raising $112 million in capital and a pair of companies acquired for $1.6 billion. Investors are backing Medical Alley companies leading a shift to a consumer- and patient-centric healthcare system. Building on a record 2017, Medical Alley’s leadership continued in a record Q1 that saw $112 million raised […]